# Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/infliximab-against-severe-covid-19-induced-cytokine-storm-syndrome-with-organ/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Andreas Stallmach,Andreas Kortgen,Falk A. Gonnert,Sina M. Coldewey,Philipp A. Reuken,Michael Bauer |
| Citations | 91 |
| DOI | 10.1186/s13054-020-03158-0 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://ccforum.biomedcentral.com/counter/pdf/10.1186/s13054-020-03158-0 |
| OpenAlex ID | https://openalex.org/W3042928294 |
| PMID | 32680535 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Philipp A. Reuken](https://scholariq.org/researchers/philipp-a-reuken/)

## Paper primary topic

- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)

## Paper topics

- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Inflammasome and immune disorders](https://scholariq.org/topics/inflammasome-and-immune-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.